Vaccines to prevent or ease the symptoms of COVID-19 were eagerly awaited in 2020 during the heart of the public health crisis. A contract development and manufacturing organization in Grand Rapids, Mich., was called upon to make the vaccines right at the same time that the firm’s new injectable filling facility was opening.
Increased demand from other customers only added to the need for more space at Grand River Aseptic Manufacturing (GRAM), which fills biologics, small molecules and vaccines used to prevent and treat a wide range of illnesses.